BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 15972722)

  • 21. Molecular and biochemical investigations of patients with intermediate or severe hyperhomocysteinemia.
    Sørensen JT; Gaustadnes M; Stabler SP; Allen RH; Mudd SH; Hvas AM
    Mol Genet Metab; 2016 Mar; 117(3):344-50. PubMed ID: 26750749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystathionine beta-synthase deficiency in Georgia (USA): correlation of clinical and biochemical phenotype with genotype.
    Kruger WD; Wang L; Jhee KH; Singh RH; Elsas LJ
    Hum Mutat; 2003 Dec; 22(6):434-41. PubMed ID: 14635102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70.
    Singh LR; Gupta S; Honig NH; Kraus JP; Kruger WD
    PLoS Genet; 2010 Jan; 6(1):e1000807. PubMed ID: 20066033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of two pathogenic mutations in cystathionine beta-synthase: different intracellular locations for wild-type and mutant proteins.
    Casique L; Kabil O; Banerjee R; Martinez JC; De Lucca M
    Gene; 2013 Nov; 531(1):117-24. PubMed ID: 23981774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.
    Guttormsen AB; Ueland PM; Kruger WD; Kim CE; Ose L; Følling I; Refsum H
    Am J Med Genet; 2001 May; 100(3):204-13. PubMed ID: 11343305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice.
    Lee HO; Wang L; Kuo YM; Andrews AJ; Gupta S; Kruger WD
    Mol Genet Metab Rep; 2018 Jun; 15():15-21. PubMed ID: 30023284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction of disease-causing CBS mutations in yeast.
    Shan X; Kruger WD
    Nat Genet; 1998 May; 19(1):91-3. PubMed ID: 9590298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced response of Cystathionine Beta-Synthase (CBS) to S-Adenosylmethionine (SAM): Identification and functional analysis of CBS gene mutations in Homocystinuria patients.
    Mendes MI; Colaço HG; Smith DE; Ramos RJ; Pop A; van Dooren SJ; Tavares de Almeida I; Kluijtmans LA; Janssen MC; Rivera I; Salomons GS; Leandro P; Blom HJ
    J Inherit Metab Dis; 2014 Mar; 37(2):245-54. PubMed ID: 23974653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystathionine beta-synthase p.S466L mutation causes hyperhomocysteinemia in mice.
    Gupta S; Wang L; Hua X; Krijt J; Kozich V; Kruger WD
    Hum Mutat; 2008 Aug; 29(8):1048-54. PubMed ID: 18454451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria.
    Kim CE; Gallagher PM; Guttormsen AB; Refsum H; Ueland PM; Ose L; Folling I; Whitehead AS; Tsai MY; Kruger WD
    Hum Mol Genet; 1997 Dec; 6(13):2213-21. PubMed ID: 9361025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model.
    Bublil EM; Majtan T; Park I; Carrillo RS; Hůlková H; Krijt J; Kožich V; Kraus JP
    J Clin Invest; 2016 Jun; 126(6):2372-84. PubMed ID: 27183385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tract.
    Skvorak K; Mitchell V; Teadt L; Franklin KA; Lee HO; Kruse N; Huitt-Roehl C; Hang J; Du F; Galanie S; Guan S; Aijaz H; Zhang N; Rajkovic G; Kruger WD; Ismaili MHA; Huisman G; McCluskie K; Silverman AP
    Mol Genet Metab; 2023 Aug; 139(4):107653. PubMed ID: 37463544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutral aminoaciduria in cystathionine β-synthase-deficient mice; an animal model of homocystinuria.
    Akahoshi N; Kamata S; Kubota M; Hishiki T; Nagahata Y; Matsuura T; Yamazaki C; Yoshida Y; Yamada H; Ishizaki Y; Suematsu M; Kasahara T; Ishii I
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1462-76. PubMed ID: 24761004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function.
    Majtan T; Olsen T; Sokolova J; Krijt J; Křížková M; Ida T; Ditrói T; Hansikova H; Vit O; Petrak J; Kuchař L; Kruger WD; Nagy P; Akaike T; Kožich V
    Redox Biol; 2024 Jul; 73():103222. PubMed ID: 38843767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.
    Kluijtmans LA; Boers GH; Kraus JP; van den Heuvel LP; Cruysberg JR; Trijbels FJ; Blom HJ
    Am J Hum Genet; 1999 Jul; 65(1):59-67. PubMed ID: 10364517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant adeno-associated virus mediated gene transfer in a mouse model for homocystinuria.
    Park ES; Oh HJ; Kruger WD; Jung SC; Lee JS
    Exp Mol Med; 2006 Dec; 38(6):652-61. PubMed ID: 17202841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
    Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
    Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway.
    Alberto JM; Hamelet J; Noll C; Blaise S; Bronowicki JP; Guéant JL; Delabar JM; Janel N
    Mol Genet Metab; 2007 Aug; 91(4):396-8. PubMed ID: 17562377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria.
    Majtan T; Hůlková H; Park I; Krijt J; Kožich V; Bublil EM; Kraus JP
    FASEB J; 2017 Dec; 31(12):5495-5506. PubMed ID: 28821635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
    Lu YH; Cheng LM; Huang YH; Lo MY; Wu TJ; Lin HY; Hsu TR; Niu DM
    Clin Nutr; 2015 Dec; 34(6):1155-8. PubMed ID: 25516282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.